Section 7 UEM Edgenta Berhad GOVERNANCE 212 CORPORATE GOVERNANCE OVERVIEW STATEMENT The Corporate Governance Overview Statement (“Statement”) provides an overview of the Company’s corporate governance practices, focusing on the Board’s activities and time allocation throughout the year. The Board recognises the importance of the application of the MCCG, effective stewardship and strong corporate values contributes to the success of the Company. Therefore, the Board continues to uphold the principles of good governance that are demonstrably embedded throughout the organisation. The Company is led by an effective Board, collectively responsible for its long-term success, ensuring its efficient operation, and remaining committed to maintaining strong momentum in pursuit of excellence in governance. A Board Leadership and Effectiveness A Board Leadership and Effectiveness B Effective Audit and Risk Management B Effective Audit and Risk Management C Integrity in Corporate Reporting and Meaningful Relationship with Stakeholders C Integrity in Corporate Reporting and Meaningful Relationship with Stakeholders The preparation of this Statement was guided by the following three (3) key principles:- BOARD RESPONSIBILITIES GOVERNANCE FRAMEWORK The Board is committed to fulfilling its responsibilities and obligations to its shareholders and various stakeholders. In carrying out its duties, the Board adheres to the Board Charter and the Discretionary Authority Limits which outlines the duties and responsibilities of the Board, as well as matters that the Board may delegate to the Board Committees, the Managing Director/Chief Executive Officer and Management. The Board Charter, available on the Company’s website at www.uemedgenta.com ensures effective leadership through oversight of management and monitoring of activities, performance, internal controls, risk management, policies, governance and the group’s viability. The Board’s main roles and responsibilities among others are as follows:- Establishing, reviewing and adopting the strategic plans and direction for the Group. Succession planning, including appointing, training, fixing the compensation of and where appropriate, replacing senior management. Overseeing the conduct of the Group’s business to evaluate whether the business is being properly managed. Developing and implementing an investor relations programme or Corporate Disclosure Policy for the Group. Identifying principal risks and ensuring the implementation of appropriate systems to manage these risks. Reviewing the adequacy and the integrity of the Group’s internal control systems and management information systems, including system for compliance with applicable laws, regulations, rules, directives and guidelines. This Statement is prepared in compliance with Bursa Securities Main Listing Requirements and is to be read together with the Corporate Governance Report (“CG Report”), which provides details on how the Company has applied each Practice as set out in the Malaysia Code on Corporate Governance 2021 (“MCCG”). The CG Report is available on the Company’s website at www.uemedgenta.com.
RkJQdWJsaXNoZXIy NDgzMzc=